Metraipolis › archive › dc_d2dd155d8741

Evolution of clinical benefit in cancer trials: comparing pivotal approval data with updated efficacy — Europe PMC PMID:42491088

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42491088
DOI
10.3389/fpubh.2026.1876451
License (as archived)
solo-consultazione
Archived
2026-10-18T11:38:44.272Z
SHA-256 of the archived text
fb0a1d35f48c42a202add8583903983262d4758d7b23ad9a7c25d988abeb1601
Stable URL of this page
https://metraipolis.com/documento/dc_d2dd155d8741

How to cite

Evolution of clinical benefit in cancer trials: comparing pivotal approval data with updated efficacy — Europe PMC PMID:42491088 — Europe PMC (en), https://europepmc.org/article/MED/42491088 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d2dd155d8741 (Metraipolis archive dc_d2dd155d8741, sha256 fb0a1d35f48c42a202add8583903983262d4758d7b23ad9a7c25d988abeb1601)
BibTeX
@misc{dcd2dd155d8741,
  title = {Evolution of clinical benefit in cancer trials: comparing pivotal approval data with updated efficacy — Europe PMC PMID:42491088},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42491088},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d2dd155d8741; sha256 fb0a1d35f48c42a202add8583903983262d4758d7b23ad9a7c25d988abeb1601},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42491088. Agents can read the archived copy with the MCP tool read_document.